María José Rebollo-López

Fueling Open‐Source Drug Discovery: 177 Small‐Molecule Leads against Tuberculosis

Lluís Ballell, Robert H. Bates, Rob J. Young et al. · ChemMedChem · 2013 · 310 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3

Modesto J. Remuiñán, Esther Pérez‐Herrán, Joaquín Rullás et al. · PLoS ONE · 2013 · 139 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Identification of KasA as the cellular target of an anti-tubercular scaffold

Katherine A. Abrahams, Chun-wa Chung, Sonja Ghidelli‐Disse et al. · Nature Communications · 2016 · 96 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +13

Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against<i>Mycobacterium tuberculosis</i>

Yumi Park, A. Pacitto, Tracy Bayliss et al. · ACS Infectious Diseases · 2016 · 91 citations

Life Sciences, Molecular Biology, Pharmacology +13

Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery

María José Rebollo-López, Joël Lelièvre, Daniel Álvarez-Gómez et al. · PLoS ONE · 2015 · 45 citations · Full text

Pharmacy, Bioinformatics, Medicinal Chemistry +17